Abstract
A “blunt” is a hollowed-out cigar/cigarillo from which much of the loose tobacco has been removed, and the remaining tobacco wrapper filled with cannabis. Although blunts contain significant levels of tobacco/nicotine, they are often treated as if they were exclusive cannabis products and omitted from surveys of tobacco products. Whereas the prevalence of virtually all other tobacco products is on the decline in the USA, available data suggest that the prevalence of blunt smoking is not — and in fact, it may be increasing. Blunts are most frequently used by people who self-identify as Black. As a result of misperceptions and perhaps biases, there is a dearth of scientific investigation, hence knowledge, surrounding the health effects associated with blunt smoking. Co-use of tobacco and cannabis has been reported to have additive and even synergistic adverse health effects. Lack of investigations into the health effects of tobacco products most frequently used by Black people may contribute to tobacco-related health disparities. We argue that the scientific and public health communities must treat blunts as the potentially lethal tobacco product that they are, studying their prevalence and use patterns, and investigating their adverse health effects, both short and long term.
Avoid common mistakes on your manuscript.
SCOPE OF THE PROBLEM
A “blunt” is a hollowed-out cigar or cigarillo from which much of the loose tobacco has been removed, and the remaining tobacco wrapper has been filled with cannabis.1 Although blunts contain tobacco/nicotine,2 the scientific and public health communities have treated them as if they were exclusive cannabis products, typically omitting them from surveys of tobacco products, as well as from public health messaging.3,4,5 Additionally, and perhaps consequently, blunts are often mistakenly believed to deliver only cannabis by the people who use them.6 Whereas the prevalence of virtually all other tobacco products, including combusted tobacco and even electronic cigarettes is on the decline in the USA, available data suggest that the prevalence of blunt smoking is not — and in fact, it may be increasing.5,7,8,9 Blunts are most frequently used by people who self-identify as Black,1,5,10 and current (past 30-day) blunt use has been reported to be as high as 18.5% in this vulnerable population.5,7,10,11,12 As a result of misperceptions and perhaps biases, there is a dearth of scientific investigation, hence knowledge, surrounding the health effects associated with blunt smoking.5,13 There is reason for concern, however, since co-use of tobacco and cannabis has been reported to have additive and even synergistic adverse health effects.14 The health effects of blunt smoking, a unique form of co-use, in which tobacco and cannabis are co-administrated, that is, inhaled simultaneously, have not been studied systematically, despite the increasing popularity of blunts. Lack of investigations into the health effects of tobacco products most frequently used by Black people may have contributed to tobacco-related health disparities.13,15 We argue that the scientific and public health communities must treat blunts as the potentially lethal tobacco product that they are, studying, with improved measurement tools,16 their prevalence and use patterns, including the influence of the tobacco industry on these factors, and investigating their adverse health effects, both short and long term. Only then will critical data be available with which to inform widespread public health messaging, and effective regulation.
WHO USES BLUNTS?
Perhaps more is known about the origin of blunt making than the current patterns and prevalence of blunt smoking. Blunts purportedly arose from the hip-hop youth subculture in the 1980s and 1990s, and to this day are most frequently used by young people, especially males, who self-identify as Black.1,5,10 Data reflecting prevalence and patterns of blunt smoking over years are largely unavailable for the simple reason that they have not been systematically collected. Although indisputably a tobacco product, blunts have not been a focus of tobacco control efforts and, in fact, are often omitted from surveys of tobacco product use, contributing to current knowledge gaps in their prevalence and physiologic effects. It was only in 2019 that the National Youth Tobacco Survey first included the prevalence of Cigar, Little Cigar and Cigarillo (CLCC) use in their report, and uncovered that Black and Hispanic youth were disproportionately susceptible to these products.6 Unfortunately, the prevalence of blunt use was not surveyed, an important omission. Only two national surveillance programs include questions about co-administration of cannabis and tobacco, the National Survey on Drug Use and Health (NSDUH) and the Population Assessment of Tobacco and Health (PATH) study, and these lack precision. For example, the PATH survey does not allow for distinction between blunt smokers, and blunt smokers who use cigarettes, unmodified cigars, or cigarillos in rapid succession (“blunter chasers”). Most reports that include blunts are based on targeted populations, limited to specific geographic areas, race/ethnicities, or age groups. The best data we have, based largely on these two national surveys and the qualitative and observational reports, suggest that blunt prevalence is greatest in non-Hispanic Black youth and young adults, and the prevalence of past month blunt usage ranges from 4.8 to 18.5%.5,7,9,10,11,12,17
INFLUENCE OF THE TOBACCO INDUSTRY
It is impossible to discuss the popularity of blunt smoking without acknowledging the influence of the tobacco industry. Marketing (or “co-marketing”) tactics for cigarillos highlight features that promote and facilitate their use for cannabis delivery, therefore using the appeal of cannabis to increase tobacco product sales.18 For example, the tobacco wrappers of certain brands of cigarillos popular for blunt-making feature a line of perforation, allowing easy splitting for tobacco removal, which is replaced by cannabis.19 Cigarillos called “Splitarillos” advertise this feature with the image of a zipper on the packaging.18 Additionally, cigarillos may have a cannabis-related product name or label, e.g., “Juicy bluntzilla”.18 These are just a few examples how the tobacco industry is taking advantage of the appeal of cannabis to youth to promote ongoing sales of tobacco products.
The inclusion and promotion of flavorings in cigars and cigarillos is another such tactic. Flavored cigarettes, except menthol cigarettes (also most popular with people who self-identify as Black), were banned by the Family Smoking Prevention and Tobacco Control Act in 2009. Cigars and cigarillos were not included in this flavor ban, and accordingly, cigarillo wrappers often feature menthol, candy, and fruit flavors. Unsurprisingly, flavors have been identified by young people as the leading reason why they smoke cigarillos.19 It is anticipated that there will be a federal ban on flavors on all tobacco products including cigars, cigarillos, and blunt wrappers. Tobacco-free blunt wraps are now widely available, and although the FDA is well-positioned to regulate them, it has not yet explicitly claimed this authority.20 Accordingly, the alarm bell has been sounded20 that the tobacco industry will use the tobacco-free blunt wraps, which are already marketed under names reminiscent of cigars (“…rillo”), therefore fillable with tobacco leaf, to skirt the anticipated federal flavor bans on all tobacco products, perpetuating the appeal of tobacco products to youth.
Finally, in contrast to cigarettes, for which pack sizes are regulated, no minimal pack size is mandated for cigar products, and cigarillos are sold in small resealable packs of one to three, rendering them much more affordable to cash-strapped young people. Cigarillos are also more likely to be sold in neighborhoods with a greater proportion of Black or low-income residents, with reports of targeted marketing in these communities.21,22 Although somewhat controversial,23,24,25 it appears that regulation of flavored cigarillos and wrappers, along with cigar taxing and increased minimum pack sizes, especially if implemented federally, could help contribute to a decrease in cigarillo and blunt use nationwide.26,27
WHAT DO WE KNOW ABOUT THE TOBACCO/NICOTINE CONTENT IN BLUNTS?
Also attributable to lack of scientific investigation, little is known about the tobacco/nicotine exposure from blunt smoking. The lone investigation that we could find reported the nicotine content in five different cigar wrappers used for blunt smoking.2 Nicotine was quantifiable in all five wrappers and ranged from 1.2 to 6.0 mg per cigar. Although less than the nicotine content in a tobacco cigarette, which may contain 10–15 mg of nicotine, it is not trivial. It has been estimated that 5 mg of nicotine daily is enough to establish a tobacco use disorder.28 Further, this value does not account for tobacco left in the wrapper during blunt preparation. Finally, it is important to recognize that the relationship between tobacco smoking burden and cardiovascular risk is not linear.29 Even minimal daily smoking levels, for example one to three cigarettes per day, confer significant cardiovascular risk, not dissimilar compared to the risk conferred by smoking one to three packs per day.29 Accordingly, even a small amount of tobacco/nicotine would be expected to have significant adverse health effects. This lack of fundamental knowledge regarding the range of nicotine exposures associated with blunt smoking is further evidence of the absence of scientific investigation — and perhaps interest — into the tobacco product most frequent used by Black people.
DO BLUNTS SERVE AS A REVERSE GATEWAY?
Blunts have been described as a “reverse gateway,” defined as a substance that precedes or prompts the initiation of tobacco use. Weekly or more cannabis use during adolescence has been associated with increased risk of tobacco use in adulthood, thereby serving as a reverse gateway to tobacco-only use.30 Similarly, blunt use has also been hypothesized to function as a reverse gateway, in part due to the known synergistic effects of both tobacco and cannabis on a primed endocannabinoid system that can subsequently lead to greater potential for nicotine use.14,31,32 Studies have reported that adults and adolescents who had used a blunt within the past year were up to four times more likely to start using cigarettes and up to six times more likely to use any kind of cigar compared to those who abstained from blunts and other forms of cannabis use.31,32,33 Whereas we do not know if this increased risk of initiation of tobacco-only products equates to their long-term use, the potential role of blunts as a reverse gateway highlights the urgent need for scientific data to inform potentially life-or-death decision-making in people who are choosing to initiate blunt smoking, thus preventing use of combusted tobacco-only products in this vulnerable population.
ADVERSE EFFECTS OF CO-ADMINISTRATION OF CANNABIS AND TOBACCO
Co-use of cannabis and tobacco has been associated with greater likelihood of cannabis use disorder (CUD) and poorer cannabis cessation outcomes relative to cannabis-only use.2,34,35 Blunt use has also been associated with increased substance use severity and increased difficulty in reducing both cannabis and tobacco use. For example, population studies have shown that past-year blunt smoking is linked to an overall increase in the risk of developing CUD.33 Lastly, cannabis users who prefer blunts and attempt to quit have a higher risk of relapse and/or increasing tobacco consumption to mitigate nicotine withdrawal.36
Other health effects of cannabis and tobacco co-use are understudied and largely unknown. Both substances have been linked to adverse cardiovascular outcomes, including arrhythmias and acute coronary ischemia, with co-use hypothesized to contribute to even greater adverse effects on the cardiovascular system compared to either compound alone.37,38 Co-use of cannabis and tobacco has also been associated with increased likelihood of psychosocial and behavioral problems as well as diminished lung function compared with cannabis use alone.34,39,40,41 However, research on the health effects of blunt use, which represents a unique form of co-use, that is, simultaneous co-administration of cannabis and tobacco, is scarce. A recent systematic review on co-administration revealed that most of the published literature comes from qualitative and descriptive studies, with no studies reporting the long-term health consequences of using blunts or other co-administered cannabis and tobacco products.5 Additional research is needed not only to understand the health effects of co-use, but also to determine optimal intervention strategies for cessation of both substances.
WHY DO SUCH GLARING GAPS IN KNOWLEDGE EXIST?
Although the reasons for the paucity of investigations into the health effects of this common form of cannabis and tobacco inhalation are unknown and likely complex, an important factor is the type of surveillance data available to accurately estimate the prevalence of blunt use. Challenges with gathering data related to blunt use include (1) whether blunts should be categorized as a tobacco product and therefore included in tobacco surveillance studies, or if they should be included only in cannabis use studies; (2) misperceptions of product content by users, as illustrated by the 2015–2019 NSDUH study, in which the proportion of people reporting blunt use exceeded the proportion who self-reported any cannabis use;6,16,42 (3) misperceptions that may be compounded by miscommunication, since investigators may be unfamiliar with the current lexicon/jargon, and thus use terminology not recognized by the user, consequently eliciting inaccurate, negative responses;16 (4) and biases towards vulnerable populations in whom disparities in research have long existed. All of these factors, and likely others, have resulted in the current dearth of knowledge surrounding the health effects of blunt smoking, thereby potentially contributing to longstanding tobacco-related health disparities.43
THE PROPOSAL
We propose taking a multitude of steps to understand the health effects of blunt use, with the goal of vastly reducing, or preferably, eliminating, their use. First, there must be an increase in funding for investigations into patterns and prevalence of blunt use, as well as their short- and long-term health effects. To acquire accurate data regarding who is using blunts and how often, we must also correctly classify blunts as both a tobacco and cannabis product and develop survey tools using language recognized by the people who use these products. Further, these surveys must reflect the complexity, evolution, and diversity of the cannabis market such as tobacco-free wraps, and of cannabis-use behaviors, such as blunt chasing. In acquiring these data from surveys and longitudinal studies, it will be critical to develop widespread public relations campaigns to educate people who are already using blunts, and those who are contemplating initiation, regarding the health effects of blunt smoking. In addition, research into the role of tobacco industry practices that may contribute to blunt use is necessary; these practices include sales of single cigarillos, perforated wrappers, flavored tobacco-wrappers, and tobacco-free wrappers. Understanding if and how regulation of these products can curb use will be a critical step in safeguarding youth and reducing tobacco-related health disparities.
REFERENCES
Sifaneck SJ, Johnson BD, Dunlap E. Cigars-for-blunts: choice of tobacco products by blunt smokers. J Ethn Subst Abuse. 2005;4:23-42.
Peters EN, Schauer GL, Rosenberry ZR, Pickworth WB. Does marijuana "blunt" smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking. Drug Alcohol Depend. 2016;168:119-122.
Cooper M, Park-Lee E, Ren C, Cornelius M, Jamal A, Cullen KA. Notes from the Field: E-cigarette Use Among Middle and High School Students - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1283-1285.
Cornelius ME, Loretan CG, Jamal A, Davis Lynn BC, Mayer M, Alcantara IC, Neff L. Tobacco Product Use Among Adults - United States, 2021. MMWR Morb Mortal Wkly Rep. 2023;72:475-483.
Schauer GL, Rosenberry ZR, Peters EN. Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review. Addict Behav. 2017;64:200-211.
Jackson DD, Sanders EC, Barry M, Wagner DE, Vigorita MW, Navarro MA. Unpacking Cigar Product Familiarity and Terminology among Black and Hispanic Youth: It’s All about Blunts. Int J Environ Res Public Health. 2022;19.
Ebrahimi Kalan M, Jebai R, Bursac Z, Popova L, Gautam P, Li W, Alqahtani MM, Taskin T, Atwell LL, Richards J, Ward KD, Behaleh R, Ben Taleb Z. Trends and Factors Related to Blunt Use in Middle and High School Students, 2010-2020. Pediatrics. 2021;148.
Montgomery L, Mantey DS. Correlates of Blunt Smoking Among African American, Hispanic/Latino, and White Adults: Results From the 2014 National Survey on Drug Use and Health. Subst Use Misuse. 2017;52:1449-1459.
https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health accessed February2024.
Montgomery L, Plano Clark VL, Twitty D, Budney AJ, Prochaska JJ, Winhusen T. Is it "loud" enough?: A qualitative investigation of blunt use among African American young adults. J Ethn Subst Abuse. 2022;21:747-761.
Delnevo CD, Bover-Manderski MT, Hrywna M. Cigar, marijuana, and blunt use among US adolescents: Are we accurately estimating the prevalence of cigar smoking among youth? Prev Med. 2011;52:475-476.
Trapl ES, Koopman Gonzalez SJ, Cofie L, Yoder LD, Frank J, Sterling KL. Cigar Product Modification Among High School Youth. Nicotine Tob Res. 2018;20:370-376.
Montgomery L, Bagot K. Let’s Be Blunt: Consumption Methods Matter Among Black Marijuana Smokers. J Stud Alcohol Drugs. 2016;77:451-456.
Meier E, Hatsukami DK. A review of the additive health risk of cannabis and tobacco co-use. Drug Alcohol Depend. 2016;166:6-12.
https://www.cdc.gov/tobacco/health-equity/african-american/health-burden.html (accessed2023).
Watkins SL, Karliner-Li P, Lee YO, Koester KA, Ling PM. A mixed-methods study to inform the clarity and accuracy of cannabis-use and cannabis-tobacco co-use survey measures. Drug Alcohol Depend. 2021;224:108697.
https://pathstudyinfo.nih.gov/ Accessed February 2024.
Henriksen L, Schleicher NC, Ababseh K, Johnson TO, Fortmann SP. Marijuana as a ‘concept’ flavour for cigar products: availability and price near California schools. Tob Control. 2018;27:585-588.
Giovenco DP, Miller Lo EJ, Lewis MJ, Delnevo CD. "They’re Pretty Much Made for Blunts": Product Features That Facilitate Marijuana Use Among Young Adult Cigarillo Users in the United States. Nicotine Tob Res. 2017;19:1359-1364.
Kong G, Morean ME, Davis DR, Bold KW, Krishnan-Sarin S. Tobacco-free blunt wraps: a regulatory conundrum. Tob Control. 2024;33:e136-e137.
Kong AY, Queen TL, Golden SD, Ribisl KM. Neighborhood Disparities in the Availability, Advertising, Promotion, and Youth Appeal of Little Cigars and Cigarillos, United States, 2015. Nicotine Tob Res. 2020;22:2170-2177.
Broun A, Phan L, Duarte DA, Ajith A, Jewett B, Mead-Morse EL, Choi K, Chen-Sankey J. Physical and Sociocultural Community-Level Influences on Cigar Smoking among Black Young Adults: An In-Depth Interview Investigation. Int J Environ Res Public Health. 2022;19.
Friedman AS. A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California. JAMA Pediatr. 2021;175:863-865.
Friedman AS. Clarification and Correction of Survey Wave Collection Dates in an Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California. JAMA Pediatr. 2022;176:947.
Liu J, Hartman L, Tan ASL, Winickoff JP. Youth tobacco use before and after flavoured tobacco sales restrictions in Oakland, California and San Francisco, California. Tob Control. 2023;32:e118-e120.
Timberlake DS, Rhee J, Silver LD, Padon AA, Vos RO, Unger JB, Andersen-Rodgers E. Impact of California’s tobacco and cannabis policies on the retail availability of little cigars/cigarillos and blunt wraps. Drug Alcohol Depend. 2021;228:109064.
Timberlake DS, Aviles J, Payan DD. Variation in adults’ use of flavored tobacco products by sales restrictions in California jurisdictions. Int J Drug Policy. 2023;116:104041.
Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994;331:123-125.
Pope CA, 3rd, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, Thun MJ. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009;120:941-948.
Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction. 2005;100:1518-1525.
Mayer ME, Kong G, Barrington-Trimis JL, McConnell R, Leventhal AM, Krishnan-Sarin S. Blunt and Non-Blunt Cannabis Use and Risk of Subsequent Combustible Tobacco Product Use Among Adolescents. Nicotine Tob Res. 2020;22:1409-1413.
Kreslake JM, Mills S, Liu M, Diaz MC, Kostygina G, Emery S, Hair EC. Youth and Young Adult Blunt Use Predicts Progression to Other Nicotine Product Use in the United States. Subst Use Misuse. 2024;59:263-268.
Fairman BJ, Kimmel HL, Blanco C, Compton WM. Blunt and non-blunt cannabis use associated with cigarette, e-cigarette, and cigar initiation: Findings from the population assessment of tobacco and health (PATH) study. Drug Alcohol Depend. 2023;246:109837.
Peters EN, Budney AJ, Carroll KM. Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction. 2012;107:1404-1417.
McClure EA, Rabin RA, Lee DC, Hindocha C. Treatment Implications Associated with Cannabis and Tobacco Co-Use. Curr Addict Rep. 2020;7:533-544.
Weinberger AH, Platt J, Copeland J, Goodwin RD. Is Cannabis Use Associated With Increased Risk of Cigarette Smoking Initiation, Persistence, and Relapse? Longitudinal Data From a Representative Sample of US Adults. J Clin Psychiatry. 2018;79.
Agrawal A, Budney AJ, Lynskey MT. The co-occurring use and misuse of cannabis and tobacco: a review. Addiction. 2012;107:1221-1233.
Cooper ZD, Haney M. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 2009;103:107-113.
Tucker JS, Pedersen ER, Seelam R, Dunbar MS, Shih RA, D’Amico EJ. Types of cannabis and tobacco/nicotine co-use and associated outcomes in young adulthood. Psychol Addict Behav. 2019;33:401-411.
Taylor DR, Fergusson DM, Milne BJ, Horwood LJ, Moffitt TE, Sears MR, Poulton R. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction. 2002;97:1055-1061.
Goodwin RD, Zhou C, Silverman KD, Rastogi D, Borrell LN. Cannabis use and the prevalence of current asthma among adolescents and adults in the United States. Prev Med. 2024;179:107827.
Le A, Han BH, Palamar JJ. Underreporting of past-year cannabis use on a national survey by people who smoke blunts. Subst Abus. 2022;43:349-355.
Corral I, Landrine H, Simms DA, Bess JJ. Polytobacco use and multiple-product smoking among a random community sample of African-American adults. BMJ Open. 2013;3:e003606.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest:
The authors declare that they do not have a conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sanchez, J.I., Fong, R.S., Hampilos, K. et al. Blunt Talk on “Blunts”: The Increasingly Popular Tobacco Product That Is Potentially Exacerbating Tobacco-Related Health Disparities. J GEN INTERN MED (2024). https://doi.org/10.1007/s11606-024-08980-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11606-024-08980-8